Evidence map›Paper›PMID 19778585›Full record

ArticleNeuroscience2009

Brain derived neurotrophic factor and neurotrophic factor 3 modulate neurotransmitter receptor expressions on developing spiral ganglion neurons.

W Sun, R J Salvi

Open access · greenAbstract read
In one paragraph

Article in Neuroscience, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Review
  3. Sex Differences in the Triad of Acquired Sensorineural Hearing Loss.International journal of molecular sciences · 2021
    Review
  4. Article
  5. Article
  6. Brain-derived nerve growth factor in the cochlea - a reproducibility study.Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale · 2020
    Article
  7. Article
  8. Review
  9. Memantine's action against aminoglycoside-induced ototoxicity.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2014
    Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

W SunCenter for Hearing and Deafness, Department of Communicative Disorders and Sciences, 137 Cary Hall, State University of New York at Buffalo, 3435 Main Street, Buffalo, NY 14214, USA. weisun@buffalo.edu
R J Salvi
University at Buffalo, State University of New York · US

Funding

Effect of IHC Loss on Auditory FunctionR01DC006630 · NIDCD · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI SALVI, RICHARD J · 2004 to 2008
$1.7M
Mechanisms of auditory cortex development and role of NMDA receptorsR03DC008685 · NIDCD · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI SUN, WEI · 2007 to 2009
$238k
NIDCD NIH HHS R01 DC006630NIDCD NIH HHS R01 DC06630-01NIDCD NIH HHS R03 DC008685
6 · The paper itself

Abstract

Cochlear spiral ganglion neurons (SGN) provide the only pathway for transmitting sound evoked activity from the hair cells to the central auditory system. Neurotrophic factor 3 (NT-3) and brain derived neurotrophic factor (BDNF) released from hair cells and supporting cells exert a profound effect on SGN survival and neural firing patterns; however, it is unclear what the effects NT-3 and BDNF have on the type of neurotransmitter receptors expressed on SGN. To address this question, the whole-cell patch clamp recording technique was used to determine what effect NT-3 and BDNF had on the function and expression of glutamate, GABA and glycine receptors (GlyR) on SGN of cochlea from postnatal C57 mouse. Receptor currents induced by the agonist of each receptor were recorded from SGN cultured with or without BDNF or NT-3. NT-3 and BDNF exerted different effects. NT-3, and to a lesser extent BDNF, enhanced the expression of GABA receptors and had comparatively little effect on glutamate receptors. Absence of BDNF and NT-3 resulted in the emergence of glycine-induced currents; however, GlyR currents were absent from the short term cultured SGN. In contrast, NT-3 and BDNF suppressed GlyR expression on SGN. These results indicate that NT-3 and BDNF exert a profound effect on the types of neurotransmitter receptors expressed on postnatal SGN, results that may have important implications for neural development and plasticity.

Indexed as

Action PotentialsAnimalsAnimals, NewbornBrain-Derived Neurotrophic FactorImmunohistochemistryMiceMice, Inbred C57BLNerve Growth FactorsNeuronsOrgan Culture TechniquesPatch-Clamp TechniquesReceptors, GABAReceptors, GlutamateReceptors, GlycineReceptors, NeurotransmitterSpiral GanglionBrain-Derived Neurotrophic FactorNerve Growth Factorsneurotropin 3, mouseReceptors, GABAReceptors, GlutamateReceptors, GlycineReceptors, Neurotransmitter

Identifiers

PMID19778585
PMCPMC2800942
OpenAlexW2043410409

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.